English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Improving stroke prevention in patients with atrial fibrillation (AF) is of paramount clinical importance1. Although oral anticoagulation (OAC) currently remains the mainstay of stroke preventive therapy in AF, there is a significant group of patients who cannot tolerate long-term anticoagulation treatment, largely due to an increased bleeding risk. For these patients in particular, left atrial appendage occlusion (LAAO) is being developed further as an alternative mode of stroke/embolism prevention. Since 2001, the year in which Horst Sievert, assisted by Michael Lesh, performed the first catheter-based LAAO using the percutaneous left atrial appendage transcatheter occlusion (PLAATO; ev3 Endovascular, Plymouth, MN, USA) device, and 2002 when Bernhard Meier used an AmplatzerTM device (St. Jude Medical, St. Paul, MN, USA) for the first time, significant progress in LAAO devices and implantation techniques has been achieved. In addition, it has become increasingly important to provide educational and scientific support to ensure optimal LAAO. The state of the art in this field is very nicely provided in the 2019 EHRA/ EAPCI consensus statement update. This document highlights the importance of operator training and centre readiness for LAAO programmes, describes in detail recommended implantation and management approaches for these patients, and emphasises the important role of different cardiovascular imaging modalities in pre-, periand post-interventional management2.

eurointervention

Left atrial appendage occlusion for stroke prevention – state of the art as provided in an updated EHRA/EAPCI consensus statement and future perspectives